farmacología cardiovascular
DESCRIPTION
Farmacología Cardiovascular . SISTEMA CIRCULATORIO: FUNCIONES PRINCIPALES. Transportar y distribuir sustancias esenciales a los tejidos Remover desechos metabólicos Ajustar la provisión de oxígeno y nutrientes en diferentes estados metabólicos Regulación de la temperatura corporal - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/1.jpg)
Farmacología Cardiovascular
![Page 2: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/2.jpg)
SISTEMA CIRCULATORIO: FUNCIONES PRINCIPALES
• Transportar y distribuir sustancias esenciales a los tejidos
• Remover desechos metabólicos• Ajustar la provisión de oxígeno y
nutrientes en diferentes estados metabólicos
• Regulación de la temperatura corporal• Comunicación humoral
![Page 3: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/3.jpg)
Un sistema complicado
![Page 4: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/4.jpg)
Que se puede simplificar
SERIES AND
PARALLEL CIRCUITS
![Page 5: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/5.jpg)
![Page 6: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/6.jpg)
![Page 7: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/7.jpg)
CICLO CARDIACO
![Page 8: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/8.jpg)
Potencial de acción cardíacom
v
0
-80mv
mv
0
-80mv
mv0
-80mv
ATRIUM VENTRICLE
SA NODE
time
![Page 9: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/9.jpg)
Conductacias del PA cardíaco
![Page 10: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/10.jpg)
Fast K closes Slow K opensFast K reopens
("Delayed rectifier")
Corrientes y PA cardíaco
![Page 11: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/11.jpg)
Del PA al ECG
![Page 12: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/12.jpg)
![Page 13: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/13.jpg)
![Page 14: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/14.jpg)
![Page 15: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/15.jpg)
AV NODE AND AV BLOCKSFOCUS ON N REGION
NORMAL
ECG
1ST DEGREEPROLONGUED AVCONDUCTION TIME
2ND DEGREE
1/2 ATRIAL IMPULSES CONDUCTED TO VENTRICLES
3RD DEGREE
VAGAL MEDIATIONIN N REGION/COMPLETEBLOCK
![Page 16: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/16.jpg)
![Page 17: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/17.jpg)
![Page 18: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/18.jpg)
• Cardiovascular disease is the major cause of death
• Cardiovascular function based on– Cardiac pumping ability
• Pace-making electrical signals• Force of contraction• Height of ventricle discharge pressure
– Integrity of vasculature• Presence of blockage• Muscular tone/structural integrity• Pressure drop needed to move blood to and through capillary
beds– Blood volume/composition
• Water, electrolyte, iron balances• Lipid and protein composition
ENFERMEDAD CARDÍACA
![Page 19: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/19.jpg)
Patologías cardiovasculares que requieren farmacoterapia
• Hipertensión• Arritmia• Falla cardíaca• Trastornos de flujo vascular
![Page 20: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/20.jpg)
I. Background to Hypertension -Regulation of Blood Pressure
• Arterial blood pressure due to combination of cardiac output (CO) and total peripheral resistance (TPR)
• CO – regulated by heart rate and stroke volume (CO = HR x SV)
• TPR function of – Viscosity of blood (hematocrit)– Length of blood vessels– Blood vessel luminal diameter (especially precapillary
arterioles)
![Page 21: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/21.jpg)
Cardiac Output• Heart rate
– Function of • sympathetic, vagal nervous activity• Neuro-hormonal substances
– 1° angiotensin II– 2º vasopression (anti-diuretic hormone = ADH)
• Stroke volume– Function of
• Venous return (function of venous tone [contractile state] and circulating blood (vascular) volume)
– Venous tone function of sympathetic activity (α1, α2 receptors)– Vascular volume depends on
» Intake of fluids (thirst)» Output of fluids (urine, sweat, etc)» Distribution of fluids (Starling’s law)
• Myocardial contractility (MC proportional to sympathetic tone [β1 receptors])
![Page 22: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/22.jpg)
Characteristics of some adrenoceptors (sympathetic nerves)
α1 α2 β1 β2
Smooth muscle Arteries/ veins
constrict constrict/dilate
dilate
Skeletal muscle
dilate
Heart
Rate (increase)
Force of contraction
increase
Tissues and effects receptors
![Page 23: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/23.jpg)
Autonomic Regulation of the Heart
• Heart Rate– Parasympathetic input via vagus nerve
causes decrease in HR (dominates) – Sympathetic input to sino-atrial node causes
increase in HR (usually minor)
• Heart contractility– Increased by sympathetic activity causing
release of epinephrine, norepinephrine from adrenal gland
![Page 24: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/24.jpg)
Hipertensión
![Page 25: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/25.jpg)
Antihypertensive Classes
• diuretics• beta blockers• angiotensin-converting enzyme (ACE)
inhibitors • calcium channel blockers• vasodilators
![Page 26: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/26.jpg)
Alpha1 Blockers
Stimulate alpha1 receptors -> hypertension
Block alpha1 receptors -> hypotension
• doxazosin (Cardura®)• prazosin (Minipress®)• terazosin (Hytrin®)
![Page 27: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/27.jpg)
Central Acting Adrenergics• Stimulate alpha2 receptors
– inhibit alpha1 stimulation• hypotension
• clonidine (Catapress®)• methyldopa (Aldomet®)
![Page 28: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/28.jpg)
Peripheral Acting Adrenergics
• reserpine (Serpalan®)• inhibits the release of NE• diminishes NE stores• leads to hypotension• Prominent side effect of depression
– also diminishes seratonin
![Page 29: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/29.jpg)
Adrenergic Side Effects
• Common– dry mouth, drowsiness, sedation &
constipation– orthostatic hypotension
• Less common– headache, sleep disturbances, nausea, rash
& palpitations
![Page 30: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/30.jpg)
Sistema renina-angiotensina
![Page 31: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/31.jpg)
Angiotensin I
ACE
Angiotensin II
1. potent vasoconstrictor- increases BP
2. stimulates Aldosterone- Na+ & H2Oreabsorbtion
ACE Inhibitors .
RAAS
![Page 32: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/32.jpg)
Renin-Angiotensin Aldosterone System
• Angiotensin II = vasoconstrictor• Constricts blood vessels & increases BP• Increases SVR or afterload• ACE-I blocks these effects decreasing SVR &
afterload
![Page 33: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/33.jpg)
ACE Inhibitors
• Aldosterone secreted from adrenal glands cause sodium & water reabsorption
• Increase blood volume
• Increase preload
• ACE-I blocks this and decreases preload
![Page 34: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/34.jpg)
Angiotensin Converting Enzyme Inhibitors
• captopril (Capoten®)• enalapril (Vasotec®)• lisinopril (Prinivil® & Zestril®)• quinapril (Accupril®)• ramipril (Altace®)• benazepril (Lotensin®)• fosinopril (Monopril®)
![Page 35: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/35.jpg)
Calcium Channel Blockers
• Used for:• Angina
• Tachycardias
• Hypertension
![Page 36: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/36.jpg)
Antagonistas de calcio como vasodilatadores
![Page 37: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/37.jpg)
Calcium Channel Blockers
• diltiazem (Cardizem®)
• verapamil (Calan®, Isoptin®)
• nifedipine (Procardia®, Adalat®)
![Page 38: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/38.jpg)
CCB Site of Action
diltiazem & verapamil
nifedipine (and otherdihydropyridines)
![Page 39: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/39.jpg)
CCB Action
• diltiazem & verapamil• decrease automaticity & conduction in SA & AV nodes
• decrease myocardial contractility
• decreased smooth muscle tone
• decreased PVR
• nifedipine• decreased smooth muscle tone
• decreased PVR
![Page 40: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/40.jpg)
Side Effects of CCBs
• Cardiovascular• hypotension, palpitations & tachycardia
• Gastrointestinal• constipation & nausea
• Other• rash, flushing & peripheral edema
![Page 41: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/41.jpg)
Diuretics
• Thiazides:• chlorothiazide (Diuril®) & hydrochlorothiazide (HCTZ®,
HydroDIURIL®)
• Loop Diuretics• furosemide (Lasix®), bumetanide (Bumex®)
• Potassium Sparing Diuretics• spironolactone (Aldactone®)
![Page 42: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/42.jpg)
Diuretic Site of Action
.
loop of Henle
proximaltubule
Distal tubule
Collecting duct
![Page 43: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/43.jpg)
Mechanism
• Water follows Na+
• 20-25% of all Na+ is reabsorbed into the blood stream in the loop of Henle
• 5-10% in distal tubule & 3% in collecting ducts
• If it can not be absorbed it is excreted with the urine
Blood volume = preload !
![Page 44: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/44.jpg)
Side Effects of Diuretics
• electrolyte losses [Na+ & K+ ]• fluid losses [dehydration]• myalgia• N/V/D• dizziness• hyperglycemia
![Page 45: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/45.jpg)
Vasodilators
• diazoxide [Hyperstat®]• hydralazine [Apresoline®]• minoxidil [Loniten®]• sodium Nitroprusside [Nipride®]
![Page 46: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/46.jpg)
![Page 47: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/47.jpg)
Mechanism of Vasodilators
• Directly relaxes arteriole smooth muscle• Decrease SVR = decrease afterload
![Page 48: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/48.jpg)
Nitratos como vasodilatadores
![Page 49: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/49.jpg)
Side Effects of Vasodilators
• hydralazine (Apresoline®)– Reflex tachycardia
• sodium nitroprusside (Nipride®)– Cyanide toxicity in renal failure– CNS toxicity = agitation, hallucinations, etc.
![Page 50: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/50.jpg)
II. Background to Arrhythmia - Rhythm of the Heart
• Human heart is four-chambered
• Chambers need to contract sequentially (atria, then ventricles) and in synchronicity
• Also need relaxation between contractions to allow refilling of chambers
• Above controlled electrically (Purkinje fibers allow rapid, organized spread of activation)
![Page 51: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/51.jpg)
Regulation of Heart Rate
– Primarily accomplished by sinoatrial node (SA)• Located on right atrium• Receives autonomic input• When stimulated, SA signals atrial contractile fibers
atria depolarization and contraction (primes ventricles with blood)
– Depolarization picked up by atrioventricular node (AV node) depolarizes ventricles blood discharged to pulmonary artery and dorsal aorta eventually rest of body
![Page 52: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/52.jpg)
Sequential Discharge of SA and AV nodes
![Page 53: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/53.jpg)
Dysrhythmia Generation
• Abnormal conduction
• Analogies:– One way valve– Buggies stuck in
muddy roads
![Page 54: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/54.jpg)
Antiarrítmicos: conducción cardíaca
![Page 55: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/55.jpg)
Antiarrítmicos: bloqueo de canales de sodio
![Page 56: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/56.jpg)
Warning!• All antidysrhythmics have arrythmogenic
properties• In other words, they all can CAUSE
dysrhythmias too!
![Page 57: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/57.jpg)
Class I: Sodium Channel Blockers
• Decrease Na+ movement in phases 0 and 4
• Decreases rate of propagation (conduction) via tissue with fast potential (Purkinje)– Ignores those with slow potential (SA/AV)
• Indications: ventricular dysrhythmias
![Page 58: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/58.jpg)
Class Ia Agents
• Slow conduction through ventricles
• Decrease repolarization rate– Widen QRS and QT
intervals• May promote
Torsades des Pointes!
• PDQ:– procainamide
(Pronestyl®)– disopyramide
(Norpace®)– qunidine – (Quinidex®)
![Page 59: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/59.jpg)
Class Ib Agents
• Slow conduction through ventricles
• Increase rate of repolarization
• Reduce automaticity– Effective for ectopic
foci• May have other uses
• LTMD:– lidocaine (Xylocaine®)– tocainide (Tonocard®)– mexiletine (Mexitil®)– phenytoin (Dilantin®)
![Page 60: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/60.jpg)
Class Ic Agents
• Slow conduction through ventricles, atria & conduction system
• Decrease repolarization rate
• Decrease contractility• Rare last chance drug
• flecainide (Tambocor®)
• propafenone (Rythmol®)
![Page 61: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/61.jpg)
Class II: Beta Blockers
• Beta1 receptors in heart attached to Ca++ channels– Gradual Ca++ influx responsible for
automaticity• Beta1 blockade decreases Ca++ influx
– Effects similar to Class IV (Ca++ channel blockers)
• Limited # approved for tachycardias
![Page 62: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/62.jpg)
Class II: Beta Blockers
• propranolol (Inderal®)• acebutolol (Sectral®)• esmolol (Brevibloc®)
![Page 63: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/63.jpg)
Class III: Potassium Channel Blockers
• Decreases K+ efflux during repolarization• Prolongs repolarization• Extends effective refractory period• Prototype: bretyllium tosylate (Bretylol®)
– Initial norepi discharge may cause temporary hypertension/tachycardia
– Subsequent norepi depletion may cause hypotension
![Page 64: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/64.jpg)
Class IV: Calcium Channel Blockers
• Similar effect as ß blockers
• Decrease SA/AV automaticity
• Decrease AV conductivity• Useful in breaking
reentrant circuit• Prime side effect:
hypotension & bradycardia
• verapamil (Calan®)• diltiazem (Cardizem®)
• Note: nifedipine doesn’t work on heart
![Page 65: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/65.jpg)
III. Background to Congestive Heart Failure Maintenance of Normal Heart Function
• Normal cardiac output needed to adequately perfuse peripheral organs– Provide O2, nutrients, etc– Remove CO2, metabolic wastes, etc– Maintain fluid flow from capillaries into interstitium and back into venous
system if flow reduced or pressure increased in venous system build up of interstitial fluid = edema
• Because CO is a function of– Heart Rate – determined by pacemaker cells in the sinoatrial node– Stroke volume – determined by fill rate and contractile force– Atrial/ventricular/valvular coordination
Any negative change on above can lead to inadequate perfusion and development of the syndrome of heart failure
![Page 66: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/66.jpg)
FALLA CARDÍACACAUSES: Impairment of electrical activity
Muscle damageValvular defectsCardiomyopathiesResult of drugs or toxins
PROBLEM: Maintaining circulation with a weak pump( Cardiac output & cardiac reserve; RAP)
SOLUTIONS: Sympathetic tone via baroreceptor reflex - Heart rate and contractility
-Venoconstriction ( MCP)-Vasoconstriction ( Arterial BP)
Fluid retention ( MCP)-Capillary fluid shift-ADH-Renin-angiotensin-aldosterone
![Page 67: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/67.jpg)
Glicósidos:Efectos cardíacos
![Page 68: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/68.jpg)
IV. Background to Reduced Vascular Blood Flow: Blood Vessel Anatomy and Function
• Arterial blood vessels– Smooth muscle (slow, steady contraction)– elastic tissue (stretch on systole, recoil on diastole)– Contain about 10% of blood volume– Arterioles have sphincters which regulate 70% of blood pressure
• Venous blood vessels– Highly distensible, some contractility– Contain over 50% of blood volume
• Capillaries– Tiny but contain greatest cross-sectional area to allow high exchange rate– Contain precapillary sphincters to regulate blood flow– 5% of blood volume
All vasculature under ANS and humeral control
![Page 69: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/69.jpg)
Misc. Agents
• adenosine (Adenocard®)– Decreases Ca++ influx & increases K+ efflux
via 2nd messenger pathway• Hyperpolarization of membrane• Decreased conduction velocity via slow potentials• No effect on fast potentials
• Profound side effects possible (but short-lived)
![Page 70: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/70.jpg)
Misc. Agents
• Cardiac Glycocides• digoxin (Lanoxin®)
– Inhibits NaKATP pump– Increases intracellular Ca++
• via Na+-Ca++ exchange pump– Increases contractility– Decreases AV conduction velocity
![Page 71: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/71.jpg)
Fármacos con acción cardíaca
![Page 72: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/72.jpg)
Tratamiento de la angina de pecho (angor)
![Page 73: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/73.jpg)
Tratamiento del infarto agudo de miocardio
![Page 74: Farmacología Cardiovascular](https://reader036.vdocuments.pub/reader036/viewer/2022082209/56816005550346895dcf06ab/html5/thumbnails/74.jpg)
Tratamiento del infarto agudo de miocardio